scholarly article | Q13442814 |
P819 | ADS bibcode | 2013PLoSO...876340C |
P356 | DOI | 10.1371/JOURNAL.PONE.0076340 |
P932 | PMC publication ID | 3794942 |
P698 | PubMed publication ID | 24130769 |
P5875 | ResearchGate publication ID | 257839939 |
P50 | author | Pinpin Lin | Q63656287 |
P2093 | author name string | Wei-Jan Huang | |
Ying-Jan Wang | |||
Yi-Ching Wang | |||
Yi-An Chen | |||
Yi-Shiou Chiou | |||
Hui-Wen Chiu | |||
Sheng-Yow Ho | |||
Ya-Ling Yeh | |||
P2860 | cites work | Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair | Q26863429 |
Mitochondrial apoptosis and FAK signaling disruption by a novel histone deacetylase inhibitor, HTPB, in antitumor and antimetastatic mouse models | Q27310013 | ||
Signal integration in the endoplasmic reticulum unfolded protein response | Q27860577 | ||
Lysine acetylation targets protein complexes and co-regulates major cellular functions | Q27860589 | ||
2-Hydroxyoleic acid induces ER stress and autophagy in various human glioma cell lines | Q28484630 | ||
Autophagy: renovation of cells and tissues | Q29547206 | ||
Autophagy as a regulated pathway of cellular degradation | Q29547914 | ||
Anticancer activities of histone deacetylase inhibitors | Q29616624 | ||
A novel response of cancer cells to radiation involves autophagy and formation of acidic vesicles | Q32046208 | ||
Modulation of radiation response by histone deacetylase inhibition | Q33214371 | ||
Apoptotic and autophagic cell death induced by histone deacetylase inhibitors | Q33583208 | ||
The variability of autophagy and cell death susceptibility: Unanswered questions | Q33631208 | ||
Monascuspiloin enhances the radiation sensitivity of human prostate cancer cells by stimulating endoplasmic reticulum stress and inducing autophagy | Q34339721 | ||
Triple-negative breast cancer: clinical features and patterns of recurrence | Q34658655 | ||
Radiosensitization of colorectal carcinoma cell lines by histone deacetylase inhibition | Q35005604 | ||
DNA damage and autophagy | Q35017721 | ||
Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer | Q35758280 | ||
Linking of autophagy to ubiquitin-proteasome system is important for the regulation of endoplasmic reticulum stress and cell viability | Q35916071 | ||
Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death | Q35922012 | ||
Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1 | Q36017473 | ||
Vorinostat enhances the radiosensitivity of a breast cancer brain metastatic cell line grown in vitro and as intracranial xenografts | Q36085732 | ||
A phase II trial of vorinostat (suberoylanilide hydroxamic acid) in metastatic breast cancer: a California Cancer Consortium study | Q36528653 | ||
GammaH2AX and its role in DNA double-strand break repair | Q36579390 | ||
Switch between apoptosis and autophagy: radiation-induced endoplasmic reticulum stress? | Q36766391 | ||
Expression of matrix metalloproteinase 9 in primary and recurrent breast carcinomas. | Q51370134 | ||
Comet sensitivity in assessing DNA damage and repair in different cell cycle stages. | Q53341657 | ||
In vitro and in vivo radiation resistance associated with CD3 surface antigen expression in T-lineage acute lymphoblastic leukemia | Q54283308 | ||
Eeyarestatin causes cervical cancer cell sensitization to bortezomib treatment by augmenting ER stress and CHOP expression | Q85306996 | ||
Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium. | Q36870862 | ||
Inhibition of histone deacetylation: a strategy for tumor radiosensitization | Q36935075 | ||
Histone deacetylase inhibitors: mechanisms of cell death and promise in combination cancer therapy | Q37156986 | ||
From endoplasmic-reticulum stress to the inflammatory response | Q37225354 | ||
Programmed cell death and cancer | Q37436680 | ||
Targeting the endoplasmic reticulum-stress response as an anticancer strategy | Q37616303 | ||
New frontiers in promoting tumour cell death: targeting apoptosis, necroptosis and autophagy | Q37981834 | ||
Acetylation: a novel link between double-strand break repair and autophagy | Q37994172 | ||
Strategies for the discovery and development of therapies for metastatic breast cancer | Q38015229 | ||
HDAC inhibitors: roles of DNA damage and repair | Q38054222 | ||
Vorinostat for treatment of cutaneous manifestations of advanced primary cutaneous T-cell lymphoma | Q39336768 | ||
A novel sialyltransferase inhibitor suppresses FAK/paxillin signaling and cancer angiogenesis and metastasis pathways | Q39609194 | ||
Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma | Q39641710 | ||
The role of autophagy in the treatment of pancreatic cancer with gemcitabine and ionizing radiation | Q39660599 | ||
Enhancement of radiation response in osteosarcoma and rhabdomyosarcoma cell lines by histone deacetylase inhibition | Q39677848 | ||
Combination treatment with arsenic trioxide and irradiation enhances cell-killing effects in human fibrosarcoma cells in vitro and in vivo through induction of both autophagy and apoptosis | Q39732599 | ||
Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks | Q39793584 | ||
ATM blocks tunicamycin-induced endoplasmic reticulum stress | Q39870208 | ||
Sensitization to gamma-irradiation-induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell lung cancer (NSCLC) cells | Q39875544 | ||
Combination treatment with arsenic trioxide and irradiation enhances autophagic effects in U118-MG cells through increased mitotic arrest and regulation of PI3K/Akt and ERK1/2 signaling pathways | Q39880012 | ||
Sensitization to radiation-induced DNA damage accelerates loss of bcl-2 and increases apoptosis and autophagy | Q39943635 | ||
Synergistic tumor-killing effect of radiation and berberine combined treatment in lung cancer: the contribution of autophagic cell death | Q40022622 | ||
Resveratrol inhibits heregulin-beta1-mediated matrix metalloproteinase-9 expression and cell invasion in human breast cancer cells. | Q40102871 | ||
Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci | Q40240295 | ||
HDACs link the DNA damage response, processing of double-strand breaks and autophagy | Q41979339 | ||
Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer | Q42492006 | ||
The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes | Q42511189 | ||
HDAC6 expression is correlated with better survival in breast cancer. | Q45122014 | ||
3,3'-diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5. | Q46839472 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | lung metastasis | Q1877473 |
P304 | page(s) | e76340 | |
P577 | publication date | 2013-10-10 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, enhances radiosensitivity and suppresses lung metastasis in breast cancer in vitro and in vivo | |
P478 | volume | 8 |
Q36015707 | A New Histone Deacetylase Inhibitor, MHY219, Inhibits the Migration of Human Prostate Cancer Cells via HDAC1. |
Q64253267 | Autophagy induced by SAHA affects mutant P53 degradation and cancer cell survival |
Q41593165 | Autophagy-related genes are induced by histone deacetylase inhibitor suberoylanilide hydroxamic acid via the activation of cathepsin B in human breast cancer cells |
Q36994540 | Combination of the novel histone deacetylase inhibitor YCW1 and radiation induces autophagic cell death through the downregulation of BNIP3 in triple-negative breast cancer cells in vitro and in an orthotopic mouse model |
Q94474304 | DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer |
Q38784860 | Deconvoluting the relationships between autophagy and metastasis for potential cancer therapy |
Q92152313 | Epigenetic Control of Autophagy in Cancer Cells: A Key Process for Cancer-Related Phenotypes |
Q38718506 | Garcinol sensitizes breast cancer cells to Taxol through the suppression of caspase-3/iPLA2 and NF-κB/Twist1 signaling pathways in a mouse 4T1 breast tumor model |
Q37690659 | HDAC Inhibitors and RECK Modulate Endoplasmic Reticulum Stress in Tumor Cells |
Q89218028 | HDAC9 overexpression confers invasive and angiogenic potential to triple negative breast cancer cells via modulating microRNA-206 |
Q41664067 | Histone Deacetylases as New Therapeutic Targets in Triple-negative Breast Cancer: Progress and Promises |
Q90221601 | Histone deacetylase inhibitor AR-42 inhibits breast cancer cell growth and demonstrates a synergistic effect in combination with 5-FU |
Q90398667 | Histone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory properties |
Q60028152 | Identification of brain metastasis genes and therapeutic evaluation of histone deacetylase inhibitors in a clinically relevant model of breast cancer brain metastasis |
Q35194759 | Identification of histone deacetylase inhibitors with benzoylhydrazide scaffold that selectively inhibit class I histone deacetylases |
Q37701101 | Influence of gap junction intercellular communication composed of connexin 43 on the antineoplastic effect of adriamycin in breast cancer cells |
Q28084024 | Mechanisms involved in breast cancer liver metastasis |
Q98466247 | Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor Model |
Q34706060 | New targeted therapies for breast cancer: A focus on tumor microenvironmental signals and chemoresistant breast cancers |
Q90584530 | Resveratrol inhibits ACHN cells via regulation of histone acetylation |
Q40102474 | Role of autophagy in regulating the radiosensitivity of tumor cells. |
Q36413516 | Selective inhibition of histone deacetylase 2 induces p53-dependent survivin downregulation through MDM2 proteasomal degradation |
Q33566645 | Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells |
Q35232590 | Suberoylanilide hydroxamic acid treatment reveals crosstalks among proteome, ubiquitylome and acetylome in non-small cell lung cancer A549 cell line |
Q36996317 | Synergistic effects of combined treatment with histone deacetylase inhibitor suberoylanilide hydroxamic acid and TRAIL on human breast cancer cells |
Q57105429 | The Histone Acetylation Modifications of Breast Cancer and their Therapeutic Implications |
Q34365882 | The novel Aryl hydrocarbon receptor inhibitor biseugenol inhibits gastric tumor growth and peritoneal dissemination |
Q38343562 | Untangling knots between autophagic targets and candidate drugs, in cancer therapy |
Search more.